Systemic Inflammation Index: A new hope for autoimmune disease management

FHS
April 3, 2024
3:57 am

A routine blood test that measures a patient’s inflammation levels could improve the early diagnosis and management of a wide range of debilitating autoimmune diseases.

Webinar on Early Detection of Colorectal Cancer – Exploring New Laboratory Diagnostic Options – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 18.03.2024 / 13:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed:

March 19, 2024

PhRMA and BIO say Biden’s march-in proposal creates uncertainty in industry

PhRMA president Stephen Ubl argued Thursday that the Biden administration’s new proposal on the use of march-in rights has “planted the seeds of uncertainty” around

December 15, 2023

HHS reiterates plans to allow Paxlovid access regardless of insurance – Pharmaceutical Technology

Share this article Paxlovid is a combination of nirmatrelvir and low dose ritonavir, intended for the prevention of Covid-19-associated hospitalisation or death. Credit: rarrarorro via

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.